Clinical Report: Integrative Treatment Strategy for Spasticity in MS
Overview
This study evaluates the efficacy of combining focal extracorporeal shock wave therapy (fESWT) with botulinum toxin injections (BTI) for treating spasticity in patients with multiple sclerosis (MS). Results indicate that this integrative approach provides both immediate and sustained clinical benefits.
Background
Spasticity is a prevalent and debilitating symptom in multiple sclerosis, affecting approximately 65% of patients. Traditional treatments often have side effects and may require increasing doses over time. The exploration of non-invasive treatments like fESWT offers potential for improved management of spasticity in this population.
Data Highlights
{'format': 'Ensure proper HTML table structure is maintained.'}
Key Findings
{'add_statistics': 'Include p-values or confidence intervals for all findings.'}
Clinical Implications
The combination of fESWT and BTI may enhance treatment outcomes for spasticity in MS patients, offering a non-invasive option with immediate effects. Clinicians should consider this integrative approach as part of a comprehensive management plan for spasticity.
Conclusion
The findings support the use of fESWT alongside BTI as an effective strategy for managing spasticity in multiple sclerosis, warranting further investigation and potential integration into clinical practice.
